AP543A - Process for the preparation of azamacrocyclic or acyclic aminophosphonate ester derivatives. - Google Patents
Process for the preparation of azamacrocyclic or acyclic aminophosphonate ester derivatives. Download PDFInfo
- Publication number
- AP543A AP543A APAP/P/1994/000639A AP9400639A AP543A AP 543 A AP543 A AP 543A AP 9400639 A AP9400639 A AP 9400639A AP 543 A AP543 A AP 543A
- Authority
- AP
- ARIPO
- Prior art keywords
- formula
- phosphite
- paraformaldehyde
- thf
- comprises reacting
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 66
- -1 acyclic aminophosphonate ester Chemical class 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title description 19
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 40
- 229910052757 nitrogen Inorganic materials 0.000 claims description 23
- 229930040373 Paraformaldehyde Natural products 0.000 claims description 22
- 229920002866 paraformaldehyde Polymers 0.000 claims description 22
- 125000006527 (C1-C5) alkyl group Chemical group 0.000 claims description 21
- 239000003446 ligand Substances 0.000 claims description 18
- 239000007983 Tris buffer Substances 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 claims description 14
- 230000007062 hydrolysis Effects 0.000 claims description 13
- 238000006460 hydrolysis reaction Methods 0.000 claims description 13
- XTTGYFREQJCEML-UHFFFAOYSA-N tributyl phosphite Chemical compound CCCCOP(OCCCC)OCCCC XTTGYFREQJCEML-UHFFFAOYSA-N 0.000 claims description 13
- 125000000217 alkyl group Chemical group 0.000 claims description 12
- BDZBKCUKTQZUTL-UHFFFAOYSA-N triethyl phosphite Chemical compound CCOP(OCC)OCC BDZBKCUKTQZUTL-UHFFFAOYSA-N 0.000 claims description 12
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical compound OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 claims description 11
- 238000006243 chemical reaction Methods 0.000 claims description 10
- 229910052739 hydrogen Inorganic materials 0.000 claims description 10
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 9
- 239000002585 base Substances 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 229910052700 potassium Inorganic materials 0.000 claims description 7
- 239000006184 cosolvent Substances 0.000 claims description 6
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 claims description 6
- 229910052708 sodium Inorganic materials 0.000 claims description 6
- QOPBTFMUVTXWFF-UHFFFAOYSA-N tripropyl phosphite Chemical compound CCCOP(OCCC)OCCC QOPBTFMUVTXWFF-UHFFFAOYSA-N 0.000 claims description 6
- 229940120146 EDTMP Drugs 0.000 claims description 5
- NFDRPXJGHKJRLJ-UHFFFAOYSA-N edtmp Chemical compound OP(O)(=O)CN(CP(O)(O)=O)CCN(CP(O)(O)=O)CP(O)(O)=O NFDRPXJGHKJRLJ-UHFFFAOYSA-N 0.000 claims description 5
- QBPPRVHXOZRESW-UHFFFAOYSA-N 1,4,7,10-tetraazacyclododecane Chemical compound C1CNCCNCCNCCN1 QBPPRVHXOZRESW-UHFFFAOYSA-N 0.000 claims description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
- 238000005903 acid hydrolysis reaction Methods 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- RPNUMPOLZDHAAY-UHFFFAOYSA-N Diethylenetriamine Chemical compound NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 3
- CYTQBVOFDCPGCX-UHFFFAOYSA-N trimethyl phosphite Chemical compound COP(OC)OC CYTQBVOFDCPGCX-UHFFFAOYSA-N 0.000 claims description 3
- 150000008044 alkali metal hydroxides Chemical class 0.000 claims description 2
- 150000001923 cyclic compounds Chemical class 0.000 claims description 2
- 150000003009 phosphonic acids Chemical class 0.000 claims description 2
- 239000002798 polar solvent Substances 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims 2
- VPGQJHBMALMMJQ-UHFFFAOYSA-N 1-(pyridin-2-ylmethyl)-1,4,7,10-tetrazacyclododecane Chemical compound C=1C=CC=NC=1CN1CCNCCNCCNCC1 VPGQJHBMALMMJQ-UHFFFAOYSA-N 0.000 claims 1
- BNVVMEAPZVKHHC-UHFFFAOYSA-N P1(OCCCCCCCCCO1)=O Chemical compound P1(OCCCCCCCCCO1)=O BNVVMEAPZVKHHC-UHFFFAOYSA-N 0.000 claims 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims 1
- 229940090960 diethylenetriamine pentamethylene phosphonic acid Drugs 0.000 claims 1
- DUYCTCQXNHFCSJ-UHFFFAOYSA-N dtpmp Chemical compound OP(=O)(O)CN(CP(O)(O)=O)CCN(CP(O)(=O)O)CCN(CP(O)(O)=O)CP(O)(O)=O DUYCTCQXNHFCSJ-UHFFFAOYSA-N 0.000 claims 1
- 239000011591 potassium Substances 0.000 claims 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 1
- 150000002148 esters Chemical class 0.000 description 25
- 238000005481 NMR spectroscopy Methods 0.000 description 20
- 150000001875 compounds Chemical class 0.000 description 16
- 239000007787 solid Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 8
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 238000001228 spectrum Methods 0.000 description 6
- 150000001412 amines Chemical class 0.000 description 5
- 238000004679 31P NMR spectroscopy Methods 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- RCXMQNIDOFXYDO-UHFFFAOYSA-N [4,7,10-tris(phosphonomethyl)-1,4,7,10-tetrazacyclododec-1-yl]methylphosphonic acid Chemical compound OP(O)(=O)CN1CCN(CP(O)(O)=O)CCN(CP(O)(O)=O)CCN(CP(O)(O)=O)CC1 RCXMQNIDOFXYDO-UHFFFAOYSA-N 0.000 description 3
- 125000002015 acyclic group Chemical group 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000000032 diagnostic agent Substances 0.000 description 3
- 229940039227 diagnostic agent Drugs 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000000607 proton-decoupled 31P nuclear magnetic resonance spectroscopy Methods 0.000 description 3
- VILCJCGEZXAXTO-UHFFFAOYSA-N 2,2,2-tetramine Chemical compound NCCNCCNCCN VILCJCGEZXAXTO-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000002518 distortionless enhancement with polarization transfer Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 150000002829 nitrogen Chemical group 0.000 description 2
- PTMHPRAIXMAOOB-UHFFFAOYSA-N phosphoramidic acid Chemical compound NP(O)(O)=O PTMHPRAIXMAOOB-UHFFFAOYSA-N 0.000 description 2
- 150000003141 primary amines Chemical class 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 150000003335 secondary amines Chemical class 0.000 description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- ISIJQEHRDSCQIU-UHFFFAOYSA-N tert-butyl 2,7-diazaspiro[4.5]decane-7-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCCC11CNCC1 ISIJQEHRDSCQIU-UHFFFAOYSA-N 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 description 1
- 238000004009 13C{1H}-NMR spectroscopy Methods 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- 125000006479 2-pyridyl methyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 description 1
- 229910052688 Gadolinium Inorganic materials 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229910018828 PO3H2 Inorganic materials 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical class OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 238000005349 anion exchange Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 238000005341 cation exchange Methods 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- GATNOFPXSDHULC-UHFFFAOYSA-N ethylphosphonic acid Chemical compound CCP(O)(O)=O GATNOFPXSDHULC-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000001208 nuclear magnetic resonance pulse sequence Methods 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- AQSJGOWTSHOLKH-UHFFFAOYSA-N phosphite(3-) Chemical class [O-]P([O-])[O-] AQSJGOWTSHOLKH-UHFFFAOYSA-N 0.000 description 1
- PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 description 1
- 238000000079 presaturation Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- KZUNJOHGWZRPMI-AKLPVKDBSA-N samarium-153 Chemical compound [153Sm] KZUNJOHGWZRPMI-AKLPVKDBSA-N 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/065,963 US5714604A (en) | 1993-05-06 | 1993-05-06 | Process for the preparation of azamacrocyclic or acyclic aminophosphonate ester derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AP9400639A0 AP9400639A0 (en) | 1994-07-31 |
| AP543A true AP543A (en) | 1996-10-09 |
Family
ID=22066341
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| APAP/P/1994/000639A AP543A (en) | 1993-05-06 | 1994-05-06 | Process for the preparation of azamacrocyclic or acyclic aminophosphonate ester derivatives. |
Country Status (35)
| Country | Link |
|---|---|
| US (1) | US5714604A (fr) |
| EP (1) | EP0698029B1 (fr) |
| JP (1) | JP3556669B2 (fr) |
| KR (1) | KR100311560B1 (fr) |
| CN (1) | CN1042537C (fr) |
| AP (1) | AP543A (fr) |
| AT (1) | ATE172978T1 (fr) |
| AU (1) | AU682190B2 (fr) |
| BG (1) | BG62775B1 (fr) |
| CA (1) | CA2162170C (fr) |
| CO (1) | CO4230080A1 (fr) |
| CZ (1) | CZ290993B6 (fr) |
| DE (1) | DE69414382T2 (fr) |
| DK (1) | DK0698029T3 (fr) |
| DZ (1) | DZ1777A1 (fr) |
| EE (1) | EE03159B1 (fr) |
| EG (1) | EG20296A (fr) |
| ES (1) | ES2123137T3 (fr) |
| FI (1) | FI115632B (fr) |
| HK (1) | HK1014537A1 (fr) |
| HU (1) | HU223769B1 (fr) |
| IL (1) | IL109561A (fr) |
| IS (1) | IS1735B (fr) |
| LT (1) | LT3713B (fr) |
| LV (1) | LV10867B (fr) |
| MA (1) | MA23186A1 (fr) |
| NO (1) | NO304742B1 (fr) |
| PL (1) | PL180756B1 (fr) |
| RO (1) | RO115883B1 (fr) |
| RU (1) | RU2135507C1 (fr) |
| TN (1) | TNSN94040A1 (fr) |
| TW (1) | TW273549B (fr) |
| UA (1) | UA44704C2 (fr) |
| WO (1) | WO1994026753A1 (fr) |
| ZA (1) | ZA943158B (fr) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6207826B1 (en) | 1995-03-27 | 2001-03-27 | Isis Pharmaceuticals, Inc. | Macrocyclic compounds having nitrogen-containing linkages |
| US6107482A (en) | 1995-03-27 | 2000-08-22 | Isis Pharmaceuticals, Inc. | Nitrogenous macrocyclic compounds |
| EP1191948A2 (fr) * | 1999-06-11 | 2002-04-03 | Neorx Corporation | Complexe a forte dose de radionucleides destine a la suppression de la moelle osseuse |
| US7094885B2 (en) * | 1999-07-11 | 2006-08-22 | Neorx Corporation | Skeletal-targeted radiation to treat bone-associated pathologies |
| US6794371B1 (en) * | 1999-10-18 | 2004-09-21 | The Dow Chemical Company | Aminoalkylenephosphonates for treatment of bone disorders |
| JP2003512331A (ja) * | 1999-10-18 | 2003-04-02 | ザ ダウ ケミカル カンパニー | 骨障害治療用アミノアルキレンホスホネート |
| US6565828B2 (en) * | 2000-04-07 | 2003-05-20 | Bristol-Myers Squibb Company | Macrocyclic chelants for metallopharmaceuticals |
| EP1390081A2 (fr) * | 2001-01-08 | 2004-02-25 | Neorx Corporation | Composes, compositions et methodes therapeutiques et diagnostiques |
| JP2005507005A (ja) * | 2001-10-22 | 2005-03-10 | テキサス テック ユニバーシティー | 組織特異的螢光キレート |
| US20030133872A1 (en) * | 2001-10-22 | 2003-07-17 | Kiefer Garry E. | Radiopharmaceutical agent for the treatment of early stage cancer |
| US7045116B2 (en) | 2001-12-13 | 2006-05-16 | Dow Global Technologies Inc. | Treatment of osteomyelitis with radiopharmaceuticals |
| US20050112066A1 (en) * | 2003-11-26 | 2005-05-26 | Concat Lp, A California Limited Partnership | Complexes of cyclic polyaza chelators with cations of alkaline earth metals for enhanced biological activity |
| EP1778699A4 (fr) * | 2004-08-10 | 2009-02-25 | Dow Global Technologies Inc | Chelateurs et composes chelates de ciblage |
| CN112442069A (zh) * | 2019-08-28 | 2021-03-05 | 广东广山新材料股份有限公司 | 一种带有胺基的含磷阻燃剂及其制备方法和应用 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0382582A1 (fr) * | 1989-02-10 | 1990-08-16 | Celltech Therapeutics Limited | Tetra-aza macrocycles et leurs procédés de préparation |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5362476A (en) * | 1984-10-18 | 1994-11-08 | Board Of Regents, The University Of Texas System | Alkyl phosphonate polyazamacrocyclic cheates for MRI |
| GB8817185D0 (en) * | 1988-07-19 | 1988-08-24 | Interox Chemicals Ltd | Organic polyphosphonates |
| US5342936A (en) * | 1989-02-10 | 1994-08-30 | David Parker | Tetra-aza macrocycles and processes for their preparation |
| WO1991007911A1 (fr) * | 1989-11-27 | 1991-06-13 | Concat Ltd. | Ameloration d'images d'irm d'os et de tissus apparentes a l'aide de complexes de cations paramagnetiques et de ligands de polyphosphonate |
| US5236695A (en) * | 1989-11-27 | 1993-08-17 | Concat, Ltd. | MRI image enhancement of bone and related tissue using complexes of paramagnetic cations and polyphosphonate ligands |
| US5385893A (en) * | 1993-05-06 | 1995-01-31 | The Dow Chemical Company | Tricyclopolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents |
| US5606053A (en) * | 1995-05-02 | 1997-02-25 | Johnson Matthey Plc | Process for preparing 1,1'-[1,4-phenylenebis-(methylene)]-bis-1,4,8,11-tetraazacyclotetradecane |
-
1993
- 1993-05-06 US US08/065,963 patent/US5714604A/en not_active Expired - Lifetime
-
1994
- 1994-05-04 EP EP94917333A patent/EP0698029B1/fr not_active Expired - Lifetime
- 1994-05-04 AT AT94917333T patent/ATE172978T1/de not_active IP Right Cessation
- 1994-05-04 WO PCT/US1994/005134 patent/WO1994026753A1/fr active IP Right Grant
- 1994-05-04 PL PL94311651A patent/PL180756B1/pl not_active IP Right Cessation
- 1994-05-04 HU HU9503175A patent/HU223769B1/hu not_active IP Right Cessation
- 1994-05-04 DK DK94917333T patent/DK0698029T3/da active
- 1994-05-04 DE DE69414382T patent/DE69414382T2/de not_active Expired - Lifetime
- 1994-05-04 KR KR1019950704944A patent/KR100311560B1/ko not_active IP Right Cessation
- 1994-05-04 DZ DZ940043A patent/DZ1777A1/fr active
- 1994-05-04 CA CA002162170A patent/CA2162170C/fr not_active Expired - Fee Related
- 1994-05-04 JP JP52562094A patent/JP3556669B2/ja not_active Expired - Fee Related
- 1994-05-04 RO RO95-01927A patent/RO115883B1/ro unknown
- 1994-05-04 CZ CZ19952890A patent/CZ290993B6/cs not_active IP Right Cessation
- 1994-05-04 CN CN94192530A patent/CN1042537C/zh not_active Expired - Fee Related
- 1994-05-04 AU AU69086/94A patent/AU682190B2/en not_active Ceased
- 1994-05-04 ES ES94917333T patent/ES2123137T3/es not_active Expired - Lifetime
- 1994-05-04 UA UA95114920A patent/UA44704C2/uk unknown
- 1994-05-05 IL IL10956194A patent/IL109561A/en not_active IP Right Cessation
- 1994-05-05 RU RU95122389A patent/RU2135507C1/ru not_active IP Right Cessation
- 1994-05-05 MA MA23494A patent/MA23186A1/fr unknown
- 1994-05-05 IS IS4158A patent/IS1735B/is unknown
- 1994-05-06 CO CO94018967A patent/CO4230080A1/es unknown
- 1994-05-06 ZA ZA943158A patent/ZA943158B/xx unknown
- 1994-05-06 AP APAP/P/1994/000639A patent/AP543A/en active
- 1994-05-06 LT LTIP1925A patent/LT3713B/lt not_active IP Right Cessation
- 1994-05-06 LV LVP-94-99A patent/LV10867B/en unknown
- 1994-05-06 TN TNTNSN94040A patent/TNSN94040A1/fr unknown
- 1994-05-07 EG EG26094A patent/EG20296A/xx active
- 1994-05-18 TW TW083104130A patent/TW273549B/zh not_active IP Right Cessation
- 1994-07-14 EE EE9400087A patent/EE03159B1/xx not_active IP Right Cessation
-
1995
- 1995-11-03 FI FI955281A patent/FI115632B/fi not_active IP Right Cessation
- 1995-11-06 NO NO953800A patent/NO304742B1/no not_active IP Right Cessation
- 1995-12-05 BG BG100193A patent/BG62775B1/bg unknown
-
1998
- 1998-12-28 HK HK98115751A patent/HK1014537A1/xx not_active IP Right Cessation
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0382582A1 (fr) * | 1989-02-10 | 1990-08-16 | Celltech Therapeutics Limited | Tetra-aza macrocycles et leurs procédés de préparation |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP543A (en) | Process for the preparation of azamacrocyclic or acyclic aminophosphonate ester derivatives. | |
| Moedritzer et al. | The direct synthesis of α-aminomethylphosphonic acids. Mannich-type reactions with orthophosphorous acid | |
| JP2563954B2 (ja) | １―ヒドロキシ―３―（ｎ―メチル―ｎ―プロピルアミノ）プロパン―１，１―ジホスホン酸およびこの化合物を含有するカルシウム物質代謝疾患の治療薬 | |
| AU728902B2 (en) | Process for synthesizing phosphodiesters | |
| CZ287453B6 (cs) | Deriváty bisfosfonové kyseliny, způsob jejich přípravy a farmaceutický prostředek je obsahující | |
| RU95122389A (ru) | Способ получения производных азамакроциклических или ациклических аминофосфонатных эфиров | |
| Urbanovský et al. | Selective and clean synthesis of aminoalkyl-H-phosphinic acids from hypophosphorous acid by phospha-Mannich reaction | |
| FI83421B (fi) | Foerfarande foer framstaellning av farmakologiskt anvaendbara metylenbisfosfonsyraderivat. | |
| Gallagher et al. | MONO-AND DIALKYLATION OF ISOPROPYL PHOSPHINATE-A SIMPLE PREPARATION OF ALKYLPHOSPHINATE ESTERS1 | |
| NZ231515A (en) | Preparation of n-acylaminomethylphosphonic acid derivatives | |
| JP3206602B2 (ja) | アスコルビン酸の誘導体の製造方法 | |
| Failla et al. | SYNTHESIS AND CHARACTERIZATION OF AMINOPYRIDIN-2-YL-METHYL-PHOSPHONIC ACIDS | |
| Varga | Synthesis of bis (aminomethyl)-phosphinic acids via a Mannich reaction | |
| BG62140B1 (bg) | Метод за получаване на аминометанфосфонова киселина | |
| Juribasic et al. | Unexpected course of Kabachnik-Fields reaction in the microwave synthesis of quinoline-based α-aminophosphonates | |
| Iwamoto et al. | Preparation of alkyl dihydrogenphosphates with monomeric metaphosphate anion generated by photochemical CP bond cleavage of p-nitrobenzylphosphonic acid. | |
| Ries et al. | Synthesis of alkylphosphonates, a new class of antineoplastic agents | |
| Even et al. | Synthesis of new ligands derived from polyphosphonates partial esters | |
| PL217204B1 (pl) | Sposób wytwarzania kwasów bis(dialkiloaminometylo)fosfinowych | |
| Turhanen | Design and synthesis of novel (1-hydroxyethylidene)-1, 1-bisphosphonic acid derivatives as possible prodrugs of etidronate | |
| JP2002506871A (ja) | ３１ＰＮＭＲにおけるｐＨマーカーとしてのアミノホスホネートの使用 |